GLG Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-70,000
Closed -$2.02M 482
2016
Q1
$2.02M Buy
+70,000
New +$1.82M 0.06% 268
2015
Q4
Sell
-283,422
Closed -$10.5M 520
2015
Q3
$10.5M Sell
283,422
-76,766
-21% -$3.97M 0.28% 107
2015
Q2
$20.8M Sell
360,188
-24,897
-6% -$1.27M 0.54% 48
2015
Q1
$19.1M Sell
385,085
-193,980
-33% -$9.07M 0.64% 45
2014
Q4
$29.3M Buy
579,065
+82,466
+17% +$4.31M 0.86% 30
2014
Q3
$29.5M Buy
496,599
+190,381
+62% +$10.6M 0.68% 32
2014
Q2
$14.4M Sell
306,218
-130,488
-30% -$5.9M 0.34% 88
2014
Q1
$18.7M Buy
+436,706
New +$19.3M 0.37% 83

Other funds holding THC

GLG Partners's THC Position: Q2 2016 in Review

GLG Partners sold out of Tenet Healthcare (THC) in Q2 2016, closing a stake of 70,000 shares — an estimated $2.02M sold.

GLG Partners first reported a position in THC in Q1 2014 and held it in 8 quarters. The position peaked at $29.5M in Q3 2014. 261 funds tracked by Wall St. Rank hold THC as of Q2 2016.

  • GLG Partners reported no remaining Tenet Healthcare position as of Q2 2016 after selling out during the quarter.
  • GLG Partners sold 70,000 Tenet Healthcare shares in Q2 2016, an estimated $2.02M.
  • GLG Partners first reported a position in Tenet Healthcare in Q1 2014 and held it in 8 quarters.
  • GLG Partners's Tenet Healthcare position peaked at $29.5M in Q3 2014.
  • 261 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2016.

Based on GLG Partners's 13F filing for Q2 2016, filed 16 Aug 2016.